Completed OBSERVATIONAL NCT03405909

Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study (ESCULAP)

Standardized Contrast-enhanced Ultrasound (CEUS) -Algorithms for the Non-invasive Diagnosis of Hepatocellular Carcinoma (HCC) in High-risk-patients - a Prospective German Multicenter Study

Sponsor: University Hospital Erlangen

Conditions Cholangiocarcinoma, Intrahepatic Hepatocellular Carcinoma Liver Cancer Liver Cirrhosis Liver Diseases Liver Neoplasms

Interventions Histology MRI contrast enhanced ultrasound (CEUS)

Updated 8 times since 2018 Last updated: Feb 28, 2021 Started: Apr 21, 2018 Primary completion: Apr 6, 2019 Completion: Apr 6, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cholangiocarcinoma, Intrahepatic and Hepatocellular Carcinoma and is currently completed. University Hospital Erlangen leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Apr 2021 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jan 2021 — Apr 2021 [monthly]

Recruiting
Oct 2019 — Jan 2021 [monthly]

Recruiting

▶ Show 3 earlier versions

Jun 2018 — Oct 2019 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Feb 2018 — Apr 2018 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Erlangen

Data source: University Hospital Erlangen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Erlangen, Germany